The evolving first-line treatment of advanced non-small cell lung cancer harbouring epidermal growth factor receptor mutations.
about
The evolving first-line treatment of advanced non-small cell lung cancer harbouring epidermal growth factor receptor mutations.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
The evolving first-line treatm ...... wth factor receptor mutations.
@en
The evolving first-line treatm ...... wth factor receptor mutations.
@nl
type
label
The evolving first-line treatm ...... wth factor receptor mutations.
@en
The evolving first-line treatm ...... wth factor receptor mutations.
@nl
prefLabel
The evolving first-line treatm ...... wth factor receptor mutations.
@en
The evolving first-line treatm ...... wth factor receptor mutations.
@nl
P2860
P356
P1476
The evolving first-line treatm ...... owth factor receptor mutations
@en
P2093
Jacques De Grève
Lore Decoster
P2860
P304
P356
10.21037/TLCR.2018.03.08
P433
P577
2018-04-01T00:00:00Z